Stock Report

Download full stock data and analysis for free Last Updated: 10-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Enochian Biosciences (ENOB) Key Ratios

Stock Card factsheet share-fund-plan-icon

$1.56

up-down-arrow $0.86 (122.86%)

As on 11-Aug-2023 09:30EDT

Market cap

info icon

$31 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.4

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 95.86 -0.72 -219.06 -357.05 -271.70
Net Profit -220,471.91 -4,675,405.65 -904,983.19 -3,174.11 -1,062.21
EPS -220,471.93 -4,424,934.27 -808,409.18 -2,721.48 -874.09
Book Value -- -- -63.13 -33.00 60.73
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMJun-22Jun-21
EBIT-Margin info ----------
Net Margin info -1,774.59-151.5893,681,140.44----
Return on equity info -37.94-28.14-567,853.84-91.74-15.68
Return on Capital info -36.80-27.43---89.11-15.02
Return on Assets info -34.44-25.45-278,607.70-82.73-14.54
Debt to Equity (x) info ----0.00--0.04

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
-89.11
-15.02
-6.26
-15.27
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-567,853.84

Lower than Peers by 567,813.51

Profit after tax / Average Net worth * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
-567,853.84
-91.74
-15.68
-6.40
-15.27
Peer Median
-40.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-278,607.70

Lower than Peers by 278,576.46

Profit after tax / Average Total assets * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
-278,607.70
-82.73
-14.54
-6.06
-13.97
Peer Median
-31.24
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
--
--
--
--
Peer Median
-82.60
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

93,681,140.44

Higher than Peers by 93,681,231.73

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
93,681,140.44
--
--
-1,774.59
357.46
Peer Median
-91.30
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

--

--

Year on year growth in net sales

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
--
--
--
--
Peer Median
54.03
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-219.06

Lower than Peers by 218.05

Year on year growth in operating profit (EBIT)

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
-219.06
--
-96.26
-8.50
-34.53
Peer Median
-1.02
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-904,983.19

Lower than Peers by 904,975.66

Year on year growth in profit after tax

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
-904,983.19
-324.47
-146.19
56.78
-174.44
Peer Median
-7.53
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-808,409.18

Lower than Peers by 808,423.41

Year on year growth in earnings per share

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
-808,409.18
-2.76
-1.41
0.64
-0.59
Peer Median
14.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-61.19

Lower than Peers by 51.05

Year on year growth in book value per share

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
-61.19
--
--
--
--
Peer Median
-10.13
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
--
0.04
0.05
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

0.09

--

(Short term borrowings / Net worth)

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
0.09
--
0.00
0.00
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.33

Lower than Peers by 5.48

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
0.33
1.48
11.08
6.70
11.25
Peer Median
5.81
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.33

Lower than Peers by 5.36

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
0.33
--
--
--
11.25
Peer Median
5.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-349.34

Lower than Peers by 347.25

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
-349.34
--
-61.65
-114.34
-255,582.14
Peer Median
-2.09
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
--
--
--
--
Peer Median
19.01
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
--
--
--
--
Peer Median
0.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
-0.90
-8.74
-17.84
-6.81
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.45

Lower than Peers by 4.88

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
0.45
1.41
1.34
1.16
0.99
Peer Median
5.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-1.73

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
-1.73
-0.82
-9.58
-16.37
-14.64
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

31

Lower than Peers by 111

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Enochian Biosciences (ENOB)
31
--
--
--
--
Peer Median
142
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...